Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mythili Shastry

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Current Treatment Options in Oncology|May 2, 2023
Novel Estrogen Receptor-Targeted Agents for Breast CancerMythili Shastry, Erika Hamilton
Current Opinion in Obstetrics & Gynecology|December 11, 2012
Updates in the treatment of basal/triple-negative breast cancerMythili Shastry, Denise A Yardley
Nature Reviews. Drug Discovery|November 7, 2022
Targeting HER2-positive breast cancer: advances and future directionsSandra M Swain, Mythili Shastry, Erika Hamilton
Cancer Treatment Reviews|September 17, 2021
Targeting HER2 heterogeneity in breast cancerErika Hamilton, Mythili Shastry, S Michelle Shiller, et al.
Breast (Edinburgh, Scotland)|October 27, 2022
Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancerMythili Shastry, Saya Jacob, Hope S Rugo, et al.
Clinical Breast Cancer|November 30, 2019
Practical Treatment Strategies and Future Directions After Progression While Receiving CDK4/6 Inhibition and Endocrine Therapy in Advanced HR<sup>+</sup>/HER2<sup>-</sup> Breast CancerSarah Sammons, Mythili Shastry, Susan Dent, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 25, 2023
Rise of Antibody-Drug Conjugates: The Present and FutureMythili Shastry, Avantika Gupta, Sarat Chandarlapaty, et al.
Microbiology (Reading, England)|February 7, 2001
Species-specific inhibition of fungal protein synthesis by sordarin: identification of a sordarin-specificity region in eukaryotic elongation factor 2Mythili Shastry, Jennifer Nielsen, Theresa Ku, et al.
Virology|August 31, 2002
New targets for antivirals: the ribosomal A-site and the factors that interact with itTerri Goss Kinzy, Jason W Harger, Anne Carr-Schmid, et al.
The Journal of Biological Chemistry|November 4, 2006
Sordarin derivatives induce a novel conformation of the yeast ribosome translocation factor eEF2Rikke Søe, Ralph T Mosley, Michael Justice, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Treatment Options in Oncology|May 2, 2023
Novel Estrogen Receptor-Targeted Agents for Breast CancerMythili Shastry, Erika Hamilton
Current Opinion in Obstetrics & Gynecology|December 11, 2012
Updates in the treatment of basal/triple-negative breast cancerMythili Shastry, Denise A Yardley
Nature Reviews. Drug Discovery|November 7, 2022
Targeting HER2-positive breast cancer: advances and future directionsSandra M Swain, Mythili Shastry, Erika Hamilton
Cancer Treatment Reviews|September 17, 2021
Targeting HER2 heterogeneity in breast cancerErika Hamilton, Mythili Shastry, S Michelle Shiller, et al.
Breast (Edinburgh, Scotland)|October 27, 2022
Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancerMythili Shastry, Saya Jacob, Hope S Rugo, et al.
Clinical Breast Cancer|November 30, 2019
Practical Treatment Strategies and Future Directions After Progression While Receiving CDK4/6 Inhibition and Endocrine Therapy in Advanced HR<sup>+</sup>/HER2<sup>-</sup> Breast CancerSarah Sammons, Mythili Shastry, Susan Dent, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 25, 2023
Rise of Antibody-Drug Conjugates: The Present and FutureMythili Shastry, Avantika Gupta, Sarat Chandarlapaty, et al.
Microbiology (Reading, England)|February 7, 2001
Species-specific inhibition of fungal protein synthesis by sordarin: identification of a sordarin-specificity region in eukaryotic elongation factor 2Mythili Shastry, Jennifer Nielsen, Theresa Ku, et al.
Virology|August 31, 2002
New targets for antivirals: the ribosomal A-site and the factors that interact with itTerri Goss Kinzy, Jason W Harger, Anne Carr-Schmid, et al.
The Journal of Biological Chemistry|November 4, 2006
Sordarin derivatives induce a novel conformation of the yeast ribosome translocation factor eEF2Rikke Søe, Ralph T Mosley, Michael Justice, et al.
Pageof 3